1314902-34-5 Usage
Uses
Used in Pharmaceutical Industry:
6H-Pyrrolo[3,4-b]pyridin-5-ol is used as a key intermediate in the synthesis of various pharmaceuticals for its potential therapeutic applications. Its unique structure allows for the development of new drugs with specific biological activities.
Used in Agrochemical Industry:
6H-Pyrrolo[3,4-b]pyridin-5-ol is used as a building block in the synthesis of agrochemicals, contributing to the development of new pesticides and other agricultural products.
Used in Medicinal Chemistry Research:
6H-Pyrrolo[3,4-b]pyridin-5-ol is used as a research compound in medicinal chemistry to explore its potential biological activities and therapeutic applications, aiding in the discovery of novel treatments and therapies.
Used in Organic Synthesis:
6H-Pyrrolo[3,4-b]pyridin-5-ol is used as an intermediate in the synthesis of complex organic molecules, enabling the creation of new chemical entities with diverse applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1314902-34-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,9,0 and 2 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1314902-34:
(9*1)+(8*3)+(7*1)+(6*4)+(5*9)+(4*0)+(3*2)+(2*3)+(1*4)=125
125 % 10 = 5
So 1314902-34-5 is a valid CAS Registry Number.
1314902-34-5Relevant academic research and scientific papers
Pharmaceutically active 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
-
, (2008/06/13)
Compounds of the formula STR1 wherein one of A, B, D and E is N and the remaining three atoms are C; R1 and R2 are independently selected from hydrogen and C1 to C6 alkyl; and R3, R4, R5 and R6 are independently selected from hydrogen, halogen, hydroxy, C1 -C6 alkyl, C1 -C8 alkoxy, phenyl-C1 -C6 alkoxy, phenoxy --NR7 R8 wherein R7 and R8 are independently selected from hydrogen, C1 -C8 alkyl, C1 -C6 alkanoyl and COOR9 wherein R9 is hydrogen or C1 -C6 alkyl, cyano, COOR10 wherein R10 is hydrogen or C1 -C6 alkyl, and CONR11 R12 where R10 and R11 are independently selected from hydrogen and C1 -C6 alkyl, and the pharmaceutically acceptable salts thereof. The compounds are useful psychotherapeutics and may be used in treating obesity, depression and disorders wherein aggression is a symptom.
